BRIEF-Common Asthma Treatment Reduces Need For Hospitalisation In COVID-19 Patients - Study

The University of Oxford: * COMMON ASTHMA TREATMENT REDUCES NEED FOR HOSPITALISATION IN COVID-19 PATIENTS, STUDY SUGGESTS

* STOIC STUDY FOUND INHALED BUDESONIDE GIVEN TO PATIENTS WITH COVID-19 WITHIN SEVEN DAYS OF ONSET OF SYMPTOMS ALSO REDUCED RECOVERY TIME * STUDY ALSO DEMONSTRATED THAT THERE WAS A REDUCTION IN PERSISTENT SYMPTOMS IN THOSE WHO RECEIVED BUDESONIDE

* PARTICIPANTS ALLOCATED BUDESONIDE INHALER HAD QUICKER RESOLUTION OF FEVER, SYMPTOMS AND FEWER PERSISTENT SYMPTOMS AFTER 28 DAYS * STOIC TRIAL WAS SUPPORTED BY ASTRAZENECA Source text : (https://bit.ly/3q40g1W) Further company coverage: